Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-12

Clinical Trial Update: The Efficacy of Budesonide/Formoterol in Cough Variant Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial update examining budesonide/formoterol for cough variant asthma; status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide/Formoterol (budesonide/formoterol)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Cough Variant Asthma | Phase 4 | Status: UNKNOWN